Cold Hands and Feet on Semaglutide: Causes, Timeline and When to Act

Step 1: Understand what is probably behind the sensation

When people start semaglutide, appetite falls sharply and caloric intake drops. The body responds to this energy deficit partly by redistributing circulation away from the periphery (hands, feet, fingers and toes) towards core organs. This is a normal physiological response to eating less, not a toxicity signal. At the same time, GLP-1 receptor agonists like semaglutide affect smooth muscle tone in blood vessel walls, which can alter peripheral vascular tone in some people. The result, for a proportion of users, is a persistent feeling of cold in the extremities, particularly during the first few weeks after starting or after a dose increase.

Reduced body fat, which insulates the body against heat loss, is another factor that becomes more relevant over months of treatment rather than days. If you notice that your hands and feet feel colder as your weight falls, that thermodynamic shift is a plausible contributor. The NHS semaglutide medicines page lists circulation-related sensations among the less common but documented effects reported in trials and post-marketing experience. Most people find the symptom manageable; a smaller number find it disruptive enough to mention to their clinical team. Worth noting either way, your prescriber cannot act on something they do not know about.

You can read more about how semaglutide works in the body on the semaglutide overview page, which covers the mechanism behind appetite regulation and metabolic change.

Step 2: Track the pattern before your next clinical check-in

The most useful thing you can do in the first few weeks is notice when the cold sensation appears and what seems to relieve or worsen it. Does it happen mainly at rest, or also during activity? Does warming the hands with gloves or a hot drink resolve it quickly, or does it linger? Does it correlate with a recent dose step upward? This kind of structured observation turns a vague complaint into something a prescriber can actually work with. Jot a quick note on your phone each time, the date, duration and severity on a simple 1–10 scale is enough.

For most people, cold hands and feet on Wegovy settle within two to four weeks of a dose change as the body recalibrates. If you are a few months into treatment and the symptom has not improved, or if it began at a later dose step and feels worse than before, flag it at your next review. At nume, your prescriber reads every repeat-order consultation personally (nothing goes to an algorithm) so the check-in field is the right place to mention it. If the sensation is accompanied by skin colour changes (white, blue or red in sequence), significant pain, or numbness that does not resolve with warmth, that pattern can indicate Raynaud's phenomenon or another circulatory condition that needs clinical assessment promptly. The cold hands on Wegovy page covers that distinction in more detail.

Practical tracking also helps you spot improvement. Many people, once they start noting it, realise the symptom has quietly resolved, they just had not registered the absence.

Step 3: Practical measures while you wait for it to settle

Layering up is obvious but genuinely effective. Thermal gloves, wool socks and keeping core temperature stable all support peripheral circulation without any intervention to the medicine. Staying hydrated matters too, dehydration concentrates blood away from the extremities, and GI side effects like nausea or diarrhoea in the early weeks can affect fluid balance more than people realise. Eating enough protein is another factor worth raising with your prescriber: very low caloric intake on a semaglutide regime can reduce lean muscle mass, and muscle generates heat. Aim to eat well within whatever appetite you have rather than treating appetite suppression as a cue to eat as little as possible.

Light exercise, even a ten-minute walk before the school run, helps circulation in a straightforward, evidence-consistent way. Avoid smoking, which constricts peripheral vessels. Caffeine can also cause transient peripheral vasoconstriction in sensitive individuals, so if you find the sensation is worst first thing in the morning (before the tablet or after a strong coffee) that timing might be informative. For a broader look at what Wegovy treatment involves day to day, the Wegovy treatment page is a good companion read, and you can explore weight-loss treatment options more broadly if you are still in the early stages of deciding.

One thing not to do: adjust your dose, timing or injection site in response to this symptom without talking to your prescriber first. The semaglutide dose schedule is set for clinical reasons, and self-titrating in either direction is not advisable. If you are finding that semaglutide is making you feel cold more generally, not just in the hands, that page looks at why the medicine can affect body temperature beyond the extremities. The cold hands on Wegovy experience also has a specific counterpart worth reading, the cold feet on Wegovy page addresses whether the two symptoms together change the clinical picture.

Step 4: Know when cold extremities need medical attention today, not at your next review

The overwhelming majority of people who report cold hands and feet on semaglutide are experiencing a benign, transient peripheral circulation change. A smaller number may be experiencing the onset of Raynaud's phenomenon, which is manageable and not dangerous in most cases but does need a diagnosis. What requires same-day or emergency assessment is a different pattern entirely: sudden onset of cold, pale or mottled skin in one limb, especially combined with pain, weakness or loss of sensation, can indicate acute arterial insufficiency. This is rare and unrelated to semaglutide, but it is the symptom pattern that should not wait. If you are unsure whether what you are experiencing fits that description, contact your GP or call 111.

Reporting unexpected symptoms to the MHRA's Yellow Card scheme is also an option and actively encouraged, post-market surveillance is how the clinical picture of a medicine like semaglutide continues to develop after licensing. The MHRA values patient-reported data, and your experience contributes to it. If you have questions about your treatment at any point, the contact page connects you with the nume clinical team, and the FAQs page covers common treatment queries. Our clinical team reviews every consultation personally, so the right place to raise a symptom is always your prescriber first.

If you are considering semaglutide for weight management and have circulatory concerns you want to discuss before starting, a free consultation through our treatment page is the right starting point. A prescriber will review your full history and advise on suitability. You may also find it helpful to read about how Wegovy can affect the hands, which looks at the range of sensations users report in that area and what they tend to mean clinically.